Products
Harrow's IHEEZO to be available via Apexus' 340 Prime Vendor Program
New contract through the federal government program also includes access to VIGAMOX and ILEVRO.
Products
Harrow launches Iheezo for ocular surface anesthesia
Product is the first branded ocular aesthetic approved for the U.S. ophthalmic market in over a decade.
Products
CMS approves Iheezo for transitional pass-through reimbursement status
Harrow’s ocular surface anesthetic is the first to be approved in the U.S. in nearly 14 years.
Products